statistiche ricercatore

Continente	#
NA - Nord America	1.367
AS - Asia	1.017
EU - Europa	647
SA - Sud America	153
Continente sconosciuto - Info sul continente non disponibili	71
AF - Africa	25
OC - Oceania	21
Totale	3.301

Nazione	#
US - Stati Uniti d'America	1.303
SG - Singapore	284
IT - Italia	265
VN - Vietnam	217
CN - Cina	187
HK - Hong Kong	130
BR - Brasile	108
RU - Federazione Russa	77
DE - Germania	64
CA - Canada	44
IE - Irlanda	40
SE - Svezia	39
BD - Bangladesh	38
IN - India	36
GB - Regno Unito	30
FR - Francia	23
PL - Polonia	22
AR - Argentina	20
AU - Australia	20
FI - Finlandia	17
ID - Indonesia	16
KR - Corea	16
NL - Olanda	14
IQ - Iraq	13
TR - Turchia	12
ES - Italia	10
MX - Messico	10
AT - Austria	9
IR - Iran	9
ZA - Sudafrica	9
PK - Pakistan	8
UA - Ucraina	8
UZ - Uzbekistan	8
TH - Thailandia	7
DK - Danimarca	5
EC - Ecuador	5
IL - Israele	5
PH - Filippine	5
SA - Arabia Saudita	5
VE - Venezuela	5
BE - Belgio	4
CH - Svizzera	4
JP - Giappone	4
KE - Kenya	4
LT - Lituania	4
MY - Malesia	4
BO - Bolivia	3
BY - Bielorussia	3
CL - Cile	3
CO - Colombia	3
EG - Egitto	3
JM - Giamaica	3
MA - Marocco	3
NP - Nepal	3
UY - Uruguay	3
AE - Emirati Arabi Uniti	2
AL - Albania	2
AZ - Azerbaigian	2
CZ - Repubblica Ceca	2
DO - Repubblica Dominicana	2
LB - Libano	2
PE - Perù	2
PS - Palestinian Territory	2
BW - Botswana	1
BZ - Belize	1
CG - Congo	1
CY - Cipro	1
DZ - Algeria	1
EE - Estonia	1
GR - Grecia	1
GT - Guatemala	1
HN - Honduras	1
KG - Kirghizistan	1
NZ - Nuova Zelanda	1
PT - Portogallo	1
PY - Paraguay	1
RS - Serbia	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
SV - El Salvador	1
SZ - Regno dello Swaziland	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	3.231

Nome	#
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies	442
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System	430
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia	392
Characterization of Chimeric Antigen Receptors (CARs) as a potential tool for the treatment of Acute Myeloid Leukemia (AML)	313
Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use	306
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia	270
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML	257
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies	222
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas	210
Co-opting signalling molecules enables logic-gated control of CAR T cells	163
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial	155
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1	141
Totale	3.301

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	95	0	11	8	4	4	6	8	8	10	12	11	13
2022/2023	201	20	52	28	22	4	29	0	15	10	0	15	6
2023/2024	167	6	4	13	17	17	39	33	5	6	0	11	16
2024/2025	518	15	32	39	22	28	19	43	16	63	89	74	78
2025/2026	1.734	202	172	106	197	191	69	242	65	122	135	98	135
2026/2027	88	88	0	0	0	0	0	0	0	0	0	0	0
Totale													3.301

Bicocca Open Archive